I think Dr B was replaced by Locust Walk. At this
Post# of 72440
Dr B probably was retained Oct-Dec filling LW in on progress made for all advanced discussions, what things both sides in negotiations saw important and secondary and anything important needs to be known in bio terms about Brilacidin and Kevetrin and the data vault, etc. Obviously above the CEOs head. LW came in as an outsider and needed to be brought up to speed by the CMO.